Systematic review and cumulative meta-analysis of 31 RCTs in adults with rheumatoid arthritis: JAK inhibitors lowered DAS28-CRP vs placebo (MD -1.06), csDMARDs and bDMARDs, but raised serious infections vs placebo, and SAEs and MACE vs bDMARDs.
Meta-analysisn = 31 trials
O'Neill et al. The efficacy and safety of Janus kinase inhibitors in adults with rheumatoid arthritis: a systematic review and cumulative meta-analysis